Highline Medical Center

Highline Medical Center was paid $29.88M by Medicaid between Jan 2018 and Dec 2024, across 294 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	189,003	$5.19M
2019	181,218	$4.81M
2020	149,221	$4.01M
2021	156,271	$4.41M
2022	151,732	$3.98M
2023	157,561	$3.96M
2024incomplete	119,259	$3.53M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	14%	43,058	39,645	$4.23M
96361	Intravenous infusion, hydration; each additional hour	14%	14,966	12,786	$4.11M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	13%	44,577	40,268	$3.75M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	7.4%	24,787	22,166	$2.22M
70450	Computed tomography, head or brain; without contrast material	4.5%	10,192	9,444	$1.33M
74177	Computed tomography, abdomen and pelvis; with contrast material	4.2%	8,330	7,790	$1.25M
99282	Emergency department visit for the evaluation and management, low to moderate severity	3.3%	11,991	11,159	$993K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	3.0%	17,248	11,837	$884K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	2.7%	2,530	2,338	$800K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	2.6%	3,701	2,554	$765K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	2.1%	6,627	5,537	$622K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	1.8%	4,411	1,991	$526K

282 more codes

74176	Computed tomography, abdomen and pelvis; without contrast material	1.6%	2,885	$480K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.6%	4,217	$468K
45380	Colonoscopy, flexible; with biopsy, single or multiple	1.4%	1,346	$425K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	1.3%	883	$383K
76705	Ultrasound, abdominal, real time with image documentation; limited	1.2%	4,410	$353K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	1.1%	1,160	$342K
71275	Computed tomographic angiography, chest, with contrast material	1.1%	2,391	$327K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.1%	1,871	$320K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.0%	13,008	$311K
76830	Ultrasound, transvaginal	<1%	2,964	$227K
80053	Comprehensive metabolic panel	<1%	50,643	$217K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	7,133	$198K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	2,455	$171K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	3,633	$163K
93971		<1%	1,951	$155K
71046	Radiologic examination, chest; 2 views	<1%	13,160	$146K
G0378	Hospital observation service, per hour	<1%	5,108	$133K
12001		<1%	780	$133K
G0382	Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	921	$123K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	413	$119K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	15,955	$115K
76801		<1%	2,416	$114K
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,929	$113K
84484		<1%	27,416	$112K
76642		<1%	1,564	$105K
70496		<1%	720	$103K
29125		<1%	509	$99K
G0381	Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	682	$80K
96367		<1%	1,566	$76K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,250	$75K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	839	$70K
12011		<1%	344	$60K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	25,453	$57K
10060		<1%	275	$56K
73030		<1%	4,236	$55K
72100		<1%	4,341	$53K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	29,635	$52K
83605		<1%	9,445	$49K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	134	$49K
84145		<1%	5,960	$48K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,631	$46K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,861	$46K
76770		<1%	597	$45K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	819	$43K
80048	Basic metabolic panel (calcium, ionized)	<1%	12,488	$43K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	5,874	$42K
73562		<1%	2,735	$42K
90715		<1%	2,371	$40K
70486		<1%	1,195	$39K
73130		<1%	3,596	$39K
95806		<1%	121	$38K
80047		<1%	6,281	$36K
73564		<1%	3,340	$36K
71250		<1%	820	$36K
73630		<1%	3,865	$35K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	193	$34K
73610		<1%	3,656	$34K
76536		<1%	440	$34K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	207	$34K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	3,102	$34K
87040		<1%	5,546	$33K
73560		<1%	1,637	$33K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	71,537	$32K
71045	Radiologic examination, chest; single view	<1%	17,952	$31K
72040		<1%	2,348	$30K
83880		<1%	7,512	$30K
93017		<1%	419	$30K
73502		<1%	2,690	$30K
96375	Therapeutic injection; each additional sequential IV push	<1%	19,660	$26K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	12,012	$26K
73110		<1%	2,517	$25K
70498		<1%	713	$25K
12002		<1%	126	$24K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	238	$22K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	2,956	$22K
10061		<1%	105	$20K
80076		<1%	7,742	$20K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	150	$19K
95811		<1%	55	$18K
93970		<1%	182	$16K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	14,173	$16K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	20,057	$15K
74018		<1%	2,684	$15K
77066	Tomosynthesis, mammo	<1%	616	$15K
85379		<1%	2,956	$15K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	3,542	$14K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	292	$13K
70491		<1%	100	$11K
36415	Collection of venous blood by venipuncture	<1%	16,933	$10K
83690		<1%	24,056	$9K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	4,720	$9K
77065	Tomosynthesis, mammo	<1%	352	$8K
99213	Doctor's office visit, returning patient (routine)	<1%	428	$8K
84702		<1%	6,725	$7K
73140		<1%	670	$7K
J1453	Injection, fosaprepitant, 1 mg	<1%	220	$7K
97597		<1%	206	$7K
80143		<1%	1,469	$7K
73590		<1%	1,077	$6K
76870		<1%	99	$6K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,576	$6K
72070		<1%	628	$5K
84703		<1%	12,042	$5K
80050	General health panel	<1%	1,480	$5K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	3,112	$5K
95819		<1%	36	$5K
81001		<1%	25,480	$5K
87086	Culture, bacterial; quantitative colony count, urine	<1%	8,638	$4K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	10,650	$4K
73080		<1%	740	$4K
82803		<1%	2,651	$4K
99214	Doctor's office visit, returning patient (more involved)	<1%	111	$4K
83735		<1%	4,313	$4K
82962		<1%	12,346	$4K
80179		<1%	1,393	$4K
85610		<1%	21,488	$3K
72131		<1%	166	$3K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	157	$3K
82728		<1%	1,196	$3K
87070		<1%	5,552	$3K
73070		<1%	204	$3K
96368		<1%	242	$3K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	422	$3K
82607		<1%	794	$3K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	8,087	$3K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	27	$3K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	11,238	$3K
J2704	Injection, propofol, 10 mg	<1%	10,117	$2K
72141		<1%	13	$2K
96376		<1%	5,643	$2K
G0384	Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	13	$2K
81025		<1%	8,955	$2K
73090		<1%	461	$2K
76882		<1%	27	$2K
81003		<1%	8,589	$2K
86900		<1%	2,645	$2K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	1,580	$2K
86850		<1%	1,322	$2K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,797	$2K
80051		<1%	2,345	$2K
36591		<1%	764	$2K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	40	$1K
96523		<1%	79	$1K
83550		<1%	958	$1K
87430		<1%	3,147	$1K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	2,422	$1K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	6,983	$1K
J0690	Injection, cefazolin sodium, 500 mg	<1%	3,017	$1K
59025	Fetal non-stress test	<1%	12	$1K
84100		<1%	2,100	$1K
83540		<1%	1,066	$1K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	10,005	$1K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	4,858	$1K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,161	$1K
71101		<1%	225	$1K
82565		<1%	3,215	$1K
85027		<1%	1,247	$1K
86140		<1%	3,120	$1K
97161		<1%	41	$1K
86901		<1%	2,643	$1K
87186		<1%	4,366	$1K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	6,010	$1K
74022		<1%	281	$1K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,756	$1K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	98	$1K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	4,390	$970.30
0240U		<1%	3,241	$943.78
71271		<1%	14	$780.41
84112		<1%	192	$765.42
J2060	Injection, lorazepam, 2 mg	<1%	3,934	$740.32
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	6,722	$715.45
73700		<1%	12	$686.58
82746		<1%	484	$683.17
90686		<1%	85	$626.13
82330		<1%	3,613	$621.45
82378		<1%	163	$587.03
82550		<1%	1,233	$569.73
94010		<1%	30	$564.88
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,478	$549.73
94729		<1%	42	$549.21
84443	Thyroid stimulating hormone (TSH)	<1%	934	$525.02
87205		<1%	2,711	$520.27
97116		<1%	38	$492.28
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	31	$450.82
J0780	Injection, prochlorperazine, up to 10 mg	<1%	723	$439.18
87210		<1%	890	$412.77
J1170	Injection, hydromorphone, up to 4 mg	<1%	5,310	$378.90
J3490	Unclassified drugs	<1%	183	$376.44
80061	Lipid panel	<1%	150	$366.06
87510		<1%	39	$364.69
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	209	$353.76
87147		<1%	849	$350.78
J7120	Ringers lactate infusion, up to 1000 cc	<1%	5,448	$335.22
71100		<1%	43	$331.03
94726		<1%	27	$329.38
J2550	Injection, promethazine hcl, up to 50 mg	<1%	478	$322.06
82010		<1%	1,043	$319.52
J1940	Injection, furosemide, up to 20 mg	<1%	358	$313.20
11045		<1%	62	$289.91
77080		<1%	14	$277.49
87077		<1%	1,804	$270.30
85730		<1%	2,953	$269.58
97162		<1%	13	$260.50
93798		<1%	62	$250.08
85652		<1%	1,785	$249.64
82947		<1%	2,239	$248.60
J3475	Injection, magnesium sulfate, per 500 mg	<1%	934	$219.18
G0008	Administration of influenza virus vaccine	<1%	85	$214.63
87220		<1%	712	$205.24
J1630	Injection, haloperidol, up to 5 mg	<1%	1,582	$205.15
82075		<1%	191	$198.09
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	15	$194.47
C9113	Injection, pantoprazole sodium, per vial	<1%	202	$187.97
73620		<1%	17	$184.89
87660		<1%	39	$183.48
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	508	$182.68
81002		<1%	811	$181.62
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,489	$176.47
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	547	$108.39
83615		<1%	237	$107.92
J1644	Injection, heparin sodium, per 1000 units	<1%	2,573	$103.55
J8540	Dexamethasone, oral, 0.25 mg	<1%	250	$96.47
80164		<1%	12	$94.47
82553		<1%	15	$93.51
87807		<1%	475	$69.22
J2785	Injection, regadenoson, 0.1 mg	<1%	260	$64.00
0099U		<1%	73	$56.39
J3480	Injection, potassium chloride, per 2 meq	<1%	520	$47.34
A9270	Non-covered item or service	<1%	21,269	$46.39
82248		<1%	232	$42.58
72170		<1%	13	$41.95
73060		<1%	15	$41.33
87428		<1%	192	$34.47
82140		<1%	47	$33.62
87480		<1%	39	$29.84
0352U		<1%	195	$29.10
84132		<1%	90	$27.66
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,409	$27.52
88304		<1%	310	$25.22
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	1,111	$21.02
84550		<1%	109	$19.07
84439		<1%	12	$18.27
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	182	$16.46
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	317	$16.43
85014		<1%	81	$14.07
88342		<1%	377	$11.46
87340		<1%	26	$10.36
81015		<1%	32	$9.05
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	911	$8.95
82570		<1%	14	$8.42
86706		<1%	13	$7.50
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	104	$5.08
84156		<1%	15	$5.08
85018		<1%	91	$5.02
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	89	$4.91
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	214	$0.44
J1815	Injection, insulin, per 5 units	<1%	574	$0.18
87339		0%	124	$0.00
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	0%	348	$0.00
J1598	Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg	0%	47	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	32	$0.00
96417		0%	296	$0.00
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	0%	529	$0.00
99152		0%	150	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	104	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	65	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	46	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	81	$0.00
70360		0%	12	$0.00
G0238	Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring)	0%	162	$0.00
99153	Mod sedat endo service >5yrs	0%	281	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	209	$0.00
J1790	Injection, droperidol, up to 5 mg	0%	162	$0.00
C1769	Guide wire	0%	273	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	15	$0.00
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	0%	111	$0.00
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	0%	243	$0.00
J2469	Injection, palonosetron hcl, 25 mcg	0%	204	$0.00
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	0%	29	$0.00
J1836	Injection, metronidazole, 10 mg	0%	41	$0.00
C1889	Implantable/insertable device, not otherwise classified	0%	17	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	52	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWOOLLEY, RUSSELL (COO)